/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
With a market cap of $18.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) focuses on diagnostics, imaging systems, and surgical products for women’s health. Through its four segments: Diagnostics; Breast Health; GYN Surgical; and Skeletal Health, it provides solutions for early detection and treatment in areas like cancer, infectious diseases, and reproductive health. The company is expected to announce its Q4 earnings after the market closes on Monday, Nov. 4.
Ahead of the event, analysts expect HOLX to report a profit of $1.02 per share, an increase of 14.6% from $0.89 per share reported in the year-ago quarter. The company has surpassed the consensus estimates in the past four quarters. HOLX exceeded the consensus EPS estimate by a 3.9% margin in the last reported quarter.
